These modules included synaptic markers that already feature well-described decreases in neurodegeneration, such as VGF and NPTX2 [31–39], reinforcing their potential as reliable markers of degeneration across different neurologic diseases. This evidence concerns the gene NPTX2 and nervous system disorder.